These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 24434545)
61. Rosuvastatin attenuates Ang II--mediated cardiomyocyte hypertrophy via inhibition of LOX-1. Kang BY; Mehta JL J Cardiovasc Pharmacol Ther; 2009 Dec; 14(4):283-91. PubMed ID: 19724024 [TBL] [Abstract][Full Text] [Related]
62. Effect of rosuvastatin on obesity-induced cardiac oxidative stress in Wistar rats--a preliminary study. Ansari JA; Bhandari U; Pillai KK; Haque SE Indian J Exp Biol; 2012 Mar; 50(3):216-22. PubMed ID: 22439437 [TBL] [Abstract][Full Text] [Related]
63. Rosuvastatin changes cytokine expressions in ischemic territory and preserves heart function after acute myocardial infarction in rats. Hu X; Sun A; Xie X; Huang Z; Jia J; Yao R; Ge J J Cardiovasc Pharmacol Ther; 2013 Mar; 18(2):162-76. PubMed ID: 23139358 [TBL] [Abstract][Full Text] [Related]
64. Rosuvastatin suppresses the inflammatory responses through inhibition of c-Jun N-terminal kinase and Nuclear Factor-kappaB in endothelial cells. Kim YS; Ahn Y; Hong MH; Kim KH; Park HW; Hong YJ; Kim JH; Kim W; Jeong MH; Cho JG; Park JC; Kang JC J Cardiovasc Pharmacol; 2007 Jun; 49(6):376-83. PubMed ID: 17577102 [TBL] [Abstract][Full Text] [Related]
65. In vivo imaging of leukocyte recruitment to the atheroprone femoral artery reveals anti-inflammatory effects of rosuvastatin. Osaka M; Hagita S; Yoshida M Biomed Res Int; 2013; 2013():962369. PubMed ID: 23509822 [TBL] [Abstract][Full Text] [Related]
66. Angiotensin-II and rosuvastatin influence matrix remodeling in human mesangial cells via metalloproteinase modulation. Solini A; Rossi C; Santini E; Madec S; Salvati A; Ferrannini E J Hypertens; 2011 Oct; 29(10):1930-9. PubMed ID: 21881526 [TBL] [Abstract][Full Text] [Related]
67. Rosuvastatin restores superoxide dismutase expression and inhibits accumulation of oxidized LDL in the aortic arch of obese dyslipidemic mice. Verreth W; De Keyzer D; Davey PC; Geeraert B; Mertens A; Herregods MC; Smith G; Desjardins F; Balligand JL; Holvoet P Br J Pharmacol; 2007 Jun; 151(3):347-55. PubMed ID: 17384667 [TBL] [Abstract][Full Text] [Related]
68. Effects of rosuvastatin on cardiovascular morphology and function in an ApoE-knockout mouse model of atherosclerosis. Grönros J; Wikström J; Brandt-Eliasson U; Forsberg GB; Behrendt M; Hansson GI; Gan LM Am J Physiol Heart Circ Physiol; 2008 Nov; 295(5):H2046-53. PubMed ID: 18790840 [TBL] [Abstract][Full Text] [Related]
69. Upregulation of ecto-5'-nucleotidase by rosuvastatin increases the vasodilator response to ischemia. Meijer P; Wouters CW; van den Broek PH; de Rooij M; Scheffer GJ; Smits P; Rongen GA Hypertension; 2010 Oct; 56(4):722-7. PubMed ID: 20679180 [TBL] [Abstract][Full Text] [Related]
70. Intravenous rosuvastatin for acute stroke treatment: an animal study. Prinz V; Laufs U; Gertz K; Kronenberg G; Balkaya M; Leithner C; Lindauer U; Endres M Stroke; 2008 Feb; 39(2):433-8. PubMed ID: 18162625 [TBL] [Abstract][Full Text] [Related]
71. Chronic exposure to environmental contaminant nonylphenol exacerbates adenine-induced chronic renal insufficiency: role of signaling pathways and therapeutic impact of rosuvastatin. Yen CH; Lin KC; Leu S; Sun CK; Chang LT; Chai HT; Chung SY; Chang HW; Ko SF; Chen YT; Yip HK Eur J Pharm Sci; 2012 Aug; 46(5):455-67. PubMed ID: 22484332 [TBL] [Abstract][Full Text] [Related]
72. Pretreatment with rosuvastatin protects against focal cerebral ischemia/reperfusion injury in rats through attenuation of oxidative stress and inflammation. Ma M; Uekawa K; Hasegawa Y; Nakagawa T; Katayama T; Sueta D; Toyama K; Kataoka K; Koibuchi N; Kuratsu J; Kim-Mitsuyama S Brain Res; 2013 Jun; 1519():87-94. PubMed ID: 23632378 [TBL] [Abstract][Full Text] [Related]
73. Attenuation of vascular/neural dysfunction in Zucker rats treated with enalapril or rosuvastatin. Oltman CL; Davidson EP; Coppey LJ; Kleinschmidt TL; Lund DD; Yorek MA Obesity (Silver Spring); 2008 Jan; 16(1):82-9. PubMed ID: 18223617 [TBL] [Abstract][Full Text] [Related]
74. Effects of rosuvastatin on nitric oxide-dependent function in aorta and corpus cavernosum of diabetic mice: relationship to cholesterol biosynthesis pathway inhibition and lipid lowering. Nangle MR; Cotter MA; Cameron NE Diabetes; 2003 Sep; 52(9):2396-402. PubMed ID: 12941781 [TBL] [Abstract][Full Text] [Related]
75. Increased venous proinflammatory gene expression and intimal hyperplasia in an aorto-caval fistula model in the rat. Nath KA; Kanakiriya SK; Grande JP; Croatt AJ; Katusic ZS Am J Pathol; 2003 Jun; 162(6):2079-90. PubMed ID: 12759262 [TBL] [Abstract][Full Text] [Related]
76. Anti-hypertensive effects of Rosuvastatin are associated with decreased inflammation and oxidative stress markers in hypertensive rats. Sicard P; Delemasure S; Korandji C; Segueira-Le Grand A; Lauzier B; Guilland JC; Duvillard L; Zeller M; Cottin Y; Vergely C; Rochette L Free Radic Res; 2008 Mar; 42(3):226-36. PubMed ID: 18344117 [TBL] [Abstract][Full Text] [Related]
77. Neointimal hyperplasia in the inferior vena cava of adenine-induced chronic kidney disease rats with aortocaval fistulas. Du J; Liang L; Liu S; Yang X; Cao S; Zhang H; Su H; Gong X; Chen Q; Kong X; Xu D Clin Exp Nephrol; 2020 Nov; 24(11):1007-1014. PubMed ID: 32666345 [TBL] [Abstract][Full Text] [Related]
78. Rosuvastatin inhibits TGF-beta1 expression and alleviates myocardial fibrosis in diabetic rats. Ma YX; Li WH; Xie Q Pharmazie; 2013 May; 68(5):355-8. PubMed ID: 23802433 [TBL] [Abstract][Full Text] [Related]
80. Increased levels of 25 hydroxyvitamin D and 1,25-dihydroxyvitamin D after rosuvastatin treatment: a novel pleiotropic effect of statins? Yavuz B; Ertugrul DT; Cil H; Ata N; Akin KO; Yalcin AA; Kucukazman M; Dal K; Hokkaomeroglu MS; Yavuz BB; Tutal E Cardiovasc Drugs Ther; 2009 Aug; 23(4):295-9. PubMed ID: 19543962 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]